Nutritional Supplement

Vitamin D

  • Pain Management

    Low Back Pain

    In people with muscle pain associated with vitamin D deficiency, supplementing with the vitamin may improve pain.
    Low Back Pain
    ×
    Some studies have found that vitamin D levels are lower in people with back pain than in healthy people.1,2 In patients with muscle pain associated with vitamin D deficiency, vitamin D supplementation has resulted in improvement in the pain.3

    Tension Headache

    In preliminary research, people with chronic tension-type headaches who were also suffering from severe vitamin D deficiency experienced an improvement in their symptoms after supplementing with vitamin D and calcium.
    Tension Headache
    ×
    In a preliminary trial, eight patients had chronic tension-type headache in association with severe vitamin D deficiency. In each case, the headaches resolved after treatment with vitamin D3 (1,000 to 1,500 IU per day) and calcium (1,000 to 1,500 mg per day).4

    Fibromyalgia

    In a double-blind study of women with fibromyalgia who had low or moderately low blood levels of vitamin D, supplementing with vitamin D improved pain, compared with a placebo.
    Fibromyalgia
    ×
    In a double-blind study of women with fibromyalgia who had low or moderately low blood levels of vitamin D (25-hydroxyvitamin D), supplementing with vitamin D for 24 weeks improved pain, compared with a placebo. The amount of vitamin D used was 1,200 to 2,400 IU per day, depending on the blood level of vitamin D. The amount given was adjusted during the study, to maintain blood levels of vitamin D between 32 ng/ml and 48 ng/ml.5

    Burns

    People with a history of an extensive burn might benefit from vitamin D supplementation, since the skin may not be as effective at manufacturing vitamin D from sunlight.
    Burns
    ×
     

    Burns affecting a large proportion of the body may result in vitamin D deficiency6, potentially increasing the risk of osteoporosis, which is a frequent long-term consequence of severe burns.7 Vitamin D deficiency may result from the inability of previously burned skin to manufacture vitamin D after exposure to sunlight. People with a history of an extensive burn might benefit from vitamin D supplementation.

    Migraine Headache

    Taking large amounts of the combination of calcium and vitamin D has been reported to produce a marked reduction in the incidence of migraines in several women.
    Migraine Headache
    ×
     

    Taking large amounts of the combination of calcium (1,000 to 2,000 mg per day) and vitamin D has been reported to produce a marked reduction in the incidence of migraines in several women.8,9 However, the amount of vitamin D given to these women (usually 50,000 IU once a week), can cause adverse reactions, particularly when used in combination with calcium. This amount of vitamin D should be used only under medical supervision. Doctors often recommend that people take 800 to 1,200 mg of calcium and 400 IU of vitamin D per day. However, it is not known whether theses amounts would have an effect on migraines.

  • Bone Support

    Osteoporosis

    Vitamin D increases calcium absorption and helps make bones stronger. Vitamin D supplementation has reduced bone loss in women who don’t get enough of the vitamin from food and slowed bone loss in people with osteoporosis and in postmenopausal women. It also works with calcium to prevent some musculoskeletal causes of falls and subsequent fractures.
    Osteoporosis
    ×

    Vitamin D increases calcium absorption, and blood levels of vitamin D are directly related to the strength of bones.10 Mild deficiency of vitamin D is common in the fit, active elderly population and leads to an acceleration of age-related loss of bone mass and an increased risk of fracture.11 In double-blind research, vitamin D supplementation has reduced bone loss in women who consume insufficient vitamin D from food and slowed bone loss in people with osteoporosis12,13 and in postmenopausal women.14 However, the effect of vitamin D supplementation on osteoporosis risk remains surprisingly unclear,15,16 with some trials reporting little if any benefit.17 Moreover, trials reporting reduced risk of fracture have usually combined vitamin D with calcium supplementation,18 making it difficult to assess how much benefit is caused by supplementation with vitamin D alone.19

    Impaired balance and increased body sway are important causes of falls in elderly people with osteoporosis.20 Vitamin D works with calcium to prevent some musculoskeletal causes of falls.21 In a double-blind trial, elderly women who were given 800 IU per day of vitamin D and 1,200 mg per day of calcium had a significantly lower rate of falls and subsequent fractures than did women given the same amount of calcium alone.22 Vitamin D in the amount of 800 IU per day effectively prevented falls in a double-blind study of elderly nursing home residents, but lower amounts were ineffective.23

    Despite inconsistency in the research, many doctors recommend 400 to 800 IU per day of supplemental vitamin D, depending upon dietary intake and exposure to sunlight.

    One trial studying postmenopausal women combined hormone replacement therapy with magnesium (600 mg per day), calcium (500 mg per day), vitamin C, B vitamins, vitamin D, zinc, copper, manganese, boron, and other nutrients for an eight- to nine-month period.24 In addition, participants were told to avoid processed foods, limit protein intake, emphasize vegetable over animal protein, and limit consumption of salt, sugar, alcohol, coffee, tea, chocolate, and tobacco. Bone density increased a remarkable 11%, compared to only 0.7% in women receiving hormone replacement alone.

  • Weight Management

    Obesity

    Vitamin D insufficiency and deficiency are common in people with overweight and obesity; restoring sufficient levels with vitamin D supplements is likely to improve the response to weight loss efforts.
    Obesity
    ×
    People with obesity are more likely to have poor vitamin D status than their normal-weight counterparts, and low vitamin D may contribute to the systemic inflammation, insulin resistance, and metabolic disturbances associated with obesity.25,26 The value of vitamin D supplementation in weight loss programs is becoming increasingly apparent. In a placebo-controlled trial that included 44 vitamin D-deficient participants with obesity, supplementing a weight loss diet with 50,000 IU of vitamin D per week for 12 weeks restored healthy vitamin D status, decreased levels of a marker of inflammation, and led to greater weight and body fat reduction than diet and placebo.27 In a study with 205 overweight or obese participants enrolled in a three-month weight loss program, those with sufficient baseline vitamin D status lost more weight than those with baseline vitamin D insufficiency, and among those with vitamin D insufficiency, those who began taking 2,000 or 4,000 IU of vitamin D per day lost more weight than those who did not take vitamin D.28 Interestingly, a placebo-controlled trial in 218 women with overweight or obesity and vitamin D insufficiency who were randomly assigned to take either 2,000 IU of vitamin D daily or placebo for 12 months found only those who became vitamin D-sufficient through supplementation had greater weight loss compared to placebo.29
  • Blood Sugar and Diabetes Support

    Type 1 Diabetes

    Vitamin D is needed to support healthy immune and pancreatic function. Supplementing with vitamin D may improve blood sugar control in those with type 1 diabetes, especially in those with low vitamin D levels.
    Type 1 Diabetes
    ×

    Vitamin D is needed to regulate immune activity and research has shown it has an important role in preventing autoimmune diseases, including type 1 diabetes.30 Vitamin D receptors have been found in the pancreas where insulin is made and some, but not all, preliminary evidence suggests that supplementation might reduce the risk of developing type 1 diabetes.31,32 Case reports even suggest a combination of high-dose vitamin D and omega-3 fatty acids may completely reverse the onset of type 1 diabetes.33,34

    Vitamin D deficiency is common in people with type 1 diabetes and associated with poor glucose control. Supplementation with cholecalciferol (vitamin D3), in doses ranging from 2,000 IU per day to about 6,000 IU per day, has been shown in randomized controlled trials to slow the decline of pancreatic function in people with newly diagnosed type 1 diabetes who have not yet suffered an extensive loss of pancreatic function.35 Furthermore, the majority of the research shows vitamin D3, in doses ranging from 2,000–10,000 IU per day, improves short and long term glycemic control in people with type 1 diabetes, particularly in those with low vitamin D status, possibly by preserving beta cell function and increasing insulin production.36,37,38,39,40,41

    Type 2 Diabetes

    4,000 IU per day
    Type 2 Diabetes
    ×

    Vitamin D is now recognized as necessary for healthy immune function, regulation of inflammatory processes, insulin production, and cellular responsiveness to insulin.42,43 Vitamin D deficiency has been linked to high blood glucose levels, insulin resistance, type 2 diabetes, and diabetes complications.44,45 Numerous studies have examined the effect of vitamin D supplementation on blood glucose control in people with type 2 diabetes, and meta-analyses of randomized controlled trials have found evidence of benefits, particularly in those with vitamin D deficiency.46,47,48 One meta-analysis found a minimum dose of 4,000 IU of vitamin D per day is needed to improve blood glucose management and insulin sensitivity in people with type 2 diabetes.49

    Vitamin D is vital for both large and small blood vessel health, and deficiency has been associated with cardiovascular and microvascular diabetes complications. More research is needed to clearly establish a role for vitamin D supplementation in prevention and treatment of diabetes complications.50

    Metabolic Syndrome

    Vitamin D deficiency increases the risk of metabolic disorders.
    Metabolic Syndrome
    ×
    Vitamin D has multiple actions that affect metabolic syndrome. It has been shown to lower blood glucose levels, reduce insulin resistance, regulate blood pressure, promote body weight management, improve fat tissue function, reduce inflammation, and normalize triglyceride and cholesterol levels.51 A number of studies have linked vitamin D deficiency to increased risks of insulin resistance, type 2 diabetes, and metabolic syndrome.52,53 Supplementation appears to be helpful in those with metabolic syndrome who have poor vitamin D status.54 Until more is known about vitamin D and metabolic syndrome, it is important to maintain sufficient vitamin D levels.

    Type 2 Diabetes and Diabetic Neuropathy

    In a preliminary trial, supplementing with vitamin D per day significantly improved pain by almost 50% in patients with diabetic neuropathy.
    Type 2 Diabetes and Diabetic Neuropathy
    ×
    A preliminary trial supplementation with about 2,000 IU of vitamin D per day for 3 months significantly improved pain by almost 50% in patients with diabetic neuropathy.55
  • Immune System Support

    Influenza

    In one study, long-term vitamin D supplementation for three years significantly reduced flu and cold symptoms.
    Influenza
    ×

    In a double-blind study, African Americans who received vitamin D supplements for three years had significantly fewer symptoms of influenza or colds, when compared with women who received a placebo. The amount of vitamin D was 800 IU per day for the first two years, followed by 2,000 IU per day for one year.56

    Common Cold and Sore Throat

    Research suggests that supplementing with vitamin D may prevent upper respiratory tract infections in people who are deficient in the vitamin, but not in those who have normal vitamin D status.
    Common Cold and Sore Throat
    ×
    In a double-blind trial, supplementation with 300 IU per day of vitamin D for three months during the winter decreased the frequency of upper respiratory tract infections in Mongolian children with vitamin D deficiency.57 Vitamin D supplementation also decreased the incidence of colds in several other studies, but was ineffective in other research.585960616258 In one of the negative studies, vitamin D supplementation significantly increased the incidence of colds among African Americans, but not in the entire study population. While it is not certain why the results differed in the different studies, vitamin D seems to be most effective in children, in adults with frequent respiratory infections, and possibly in people with low baseline vitamin D status.

    Lupus

    In a double-blind trial, people who took vitamin D daily experienced a decrease in disease activity and flare-ups.
    Lupus
    ×
    People with SLE frequently have low blood levels of vitamin D (measured as 25-hydroxyvitamin D). In a double-blind trial, supplementing with 2,000 IU per day of vitamin D for 12 months significantly decreased disease activity by an average of 37%, compared with a placebo. In addition, the proportion of patients who experienced a disease flare during the study was significantly lower in the vitamin D group than in the placebo group (10% vs. 24%).63 Vitamin D in the amount of 50,000 IU once a week for 24 weeks also decreased disease activity in another study.64 A few patients taking vitamin D in the first study developed elevated levels of calcium in the blood or urine. Therefore, SLE patients interested in taking vitamin D supplements should be monitored by a doctor.

    Influenza and Children

    A study of Japanese children found that daily supplementation with vitamin D during the winter months significantly reduced the amount of times the children developed the flu.
    Influenza and Children
    ×
    In a double-blind study of Japanese children (average age, ten years), supplementation with 1,200 IU per day of vitamin D for 15 to 17 weeks during the winter significantly reduced the incidence of influenza infections by 42%, compared with a placebo.65
  • Heart and Circulatory Health

    Hypertension

    Vitamin D may reduce blood pressure in hypertensive people with vitamin D deficiency.
    Hypertension
    ×
    Vitamin D is best known for its role in calcium metabolism but is also now recognized as an important modulator of immune function, inflammatory signaling, and oxidative stress.66 Research shows vitamin D receptors exist on cells in the heart and blood vessels, indicating vitamin D also influences cardiac and vascular function. Furthermore, vitamin D affects the renin-angiotensin-aldosterone system, which controls blood pressure by regulating sodium and water balance.66,68 Low vitamin D levels have been linked to increased risk of high blood pressure and other cardiovascular conditions.69 Although supplementation has not been found to reduce blood pressure in the general population,69,71 it has been found to reduce both systolic and diastolic blood pressures in vitamin D deficient subjects with hypertension.72 Variations in the genes related to vitamin D receptors appear to contribute to susceptibility to hypertension.73

    Congestive Heart Failure

    In preliminary research, the prevalence of vitamin D deficiency was significantly higher in patients with congestive heart failure than in patients without it.
    Congestive Heart Failure
    ×
    In one study, the prevalence of vitamin D deficiency was significantly higher in patients with CHF than in patients without CHF (28% vs. 22%). In that study, heart failure patients who received vitamin D supplementation (usually 800 to 1,000 IU per day) had a 32% lower death rate, compared with heart failure patients who did not receive vitamin D supplementation.72 In a double-blind study of elderly people who had suffered a fracture, supplementing with 800 IU per day of vitamin D for 2 to 5 years significantly decreased the incidence of CHF by 25%, compared with a placebo.73

    Cardiac Arrhythmia

    One case report described relief from a type of arrhythmia after supplementing with vitamin D.
    Cardiac Arrhythmia
    ×
     

    One case of long-standing sick-sinus syndrome (another type of arrhythmia) was reported to resolve upon supplementation with 800 IU per day of vitamin D prescribed for an unrelated condition. However, it was not clear from that report whether the improvement was due to the vitamin D.74 More research is needed.

  • Stress and Mood Management

    Depression

    Some studies have shown that supplementing with vitamin D leads to improved mood.
    Depression
    ×

    Blood levels of vitamin D (measured as 25-hydroxyvitamin D) have been found to be significantly lower in people with depression than in healthy people.75Vitamin D supplementation may be associated with elevations in mood. In a double-blind trial, healthy people were given 400–800 IU per day of vitamin D3, or no vitamin D3, for five days during late winter. Results showed that vitamin D3 significantly enhanced positive mood and there was some evidence of a reduction in negative mood compared to a placebo.76 In another double-blind trial, people without depression took 600 IU of vitamin D along with 1,000 mg of calcium, or a placebo, twice daily for four weeks.77 Compared to the placebo, combined vitamin D and calcium supplementation produced significant elevations in mood that persisted at least one week after supplementation was discontinued. In still another double-blind trial, the combination of 1,500 IU per day of vitamin D and the antidepressant drug fluoxetine was more effective than fluoxetine alone in the treatment of major depression.78

    Seasonal Affective Disorder

    Supplementing with vitamin D may improve SAD in people with low levels of the vitamin.
    Seasonal Affective Disorder
    ×

    Vitamin D is well known for its effects on helping to maintain normal calcium levels, but it also exerts influence on the brain, spinal cord, and hormone-producing tissues of the body that may be important in the regulation of mood.79

    In one study, people with SAD were randomly assigned to receive either 100,000 IU of vitamin D one time only or two hours of bright-light therapy every day for one month. After one month, researchers observed a significant improvement in depression in the group that received vitamin D, but not in the group given light therapy.80 However, another double-blind study found that supplementation with 2,800 IU per day of vitamin D during the winter was not beneficial for people with SAD.81 Most of the participants in the study in which vitamin D was beneficial were deficient in vitamin D, whereas most of the participants in the negative study were not deficient. While additional research needs to be done, current evidence suggests that vitamin D supplementation may improve SAD in people with vitamin D deficiency but not in people without vitamin D deficiency.

  • Skin Protection

    Eczema

    In one preliminary trial, eczema significantly improved in people who had very low blood levels of vitamin D after supplementing with vitamin D.
    Eczema
    ×
    In a preliminary trial, adults with eczema who had very low blood levels of vitamin D (measured as 25-hydroxyvitamin D) had a significant improvement in their eczema after supplementing with 2,000 IU of vitamin D per day for three months.82 In a double-blind trial, there was a significantly greater improvement of winter-related eczema in children who received 1,000 IU per day of vitamin D for 1 month than in those who received a placebo.83 However, in another double-blind trial, supplementation with 4,000 IU per day of vitamin D for 3 weeks was not beneficial for adults with eczema. In that trial, blood levels of vitamin D were normal or slightly low prior to treatment.84

    Burns

    People with a history of an extensive burn might benefit from vitamin D supplementation, since the skin may not be as effective at manufacturing vitamin D from sunlight.
    Burns
    ×
     

    Burns affecting a large proportion of the body may result in vitamin D deficiency85, potentially increasing the risk of osteoporosis, which is a frequent long-term consequence of severe burns.86 Vitamin D deficiency may result from the inability of previously burned skin to manufacture vitamin D after exposure to sunlight. People with a history of an extensive burn might benefit from vitamin D supplementation.

    Vitiligo

    When used in combination with sun exposure, a form of vitamin D called calcipotriol may be effective in stimulating repigmentation in children with vitiligo.
    Vitiligo
    ×
     

    When used topically in combination with sun exposure, a pharmaceutical form of vitamin D, called calcipotriol, may be effective in stimulating repigmentation in children with vitiligo. In a preliminary study, children applied a cream containing calcipotriol daily and exposed themselves to sunlight for 10–15 minutes the following morning.87 After 11 months, marked to complete repigmentation occurred in 55% of the children, moderate repigmentation occurred in 22%, and little or no improvement was seen in 22%. None of the children developed new areas of vitiligo. The first evidence of repigmentation occurred within 6 to 12 weeks in the majority of the children. All participants tolerated the cream well, with approximately 17% complaining of mild, transient skin irritation. Calcipotriol is a prescription medication to be used only under the supervision of a doctor. It is not known whether vitamin D as a dietary supplement has any effect on vitiligo.

  • Women's Health

    Vaginitis

    In one double-blind trial, women with vaginitis who were not experiencing any symptoms were given vitamin D daily and had a higher cure rate than the control group.
    Vaginitis
    ×
    In a double-blind trial, women with bacterial vaginosis who were not experiencing any symptoms were given 2,000 IU of vitamin D per day or no vitamin D (control group) for 15 weeks. The cure rate was significantly higher in the vitamin D group than in the control group (63.5% vs. 19.2%).88 Vitamin D is thought to work by improving the functioning of the immune system.

    Dysmenorrhea

    In a double-blind trial, women with dysmenorrhea received a placebo or a single administration of a large amount of vitamin D, which appeared to significantly diminish menstrual pain. This should only be done under doctor supervision.
    Dysmenorrhea
    ×
    In a double-blind trial, women with dysmenorrhea received a placebo or a single administration of a large amount of vitamin D (300,000), five days before the expected onset of the next menstrual period. During the next two menstrual periods, menstrual pain was significantly lower in the vitamin D group than in the placebo group.89 Such a large amount of vitamin D should be given only under the supervision of a doctor. Further research is needed to determine whether daily supplementation of a smaller amount (such as 800 to 2,000 IU per day) would have a similar beneficial effect.

    Breast Cancer

    Vitamin D from supplements and from exposure to the sun both appear to protect against breast cancer.
    Breast Cancer
    ×

    Breast cancer rates have been reported to be relatively high in areas of low exposure to sunlight.90 Sunlight triggers the formation of vitamin D in the skin, which can be activated in the liver and kidneys into a hormone with great activity. This activated form of vitamin D causes “cellular differentiation”—essentially the opposite of cancer.

    The following evidence indicates that vitamin D might have a protective role against breast cancer:

    • Synthetic vitamin D-like molecules have prevented the equivalent of breast cancer in animals.91
    • Activated vitamin D appears to have antiestrogenic activity.92
    • Both sunlight and dietary exposure to vitamin D have correlated with a reduced risk of breast cancer.93,94

    Activated vitamin D comes in several forms. One of them—1,25 dihydroxycholecalciferol—is an exact duplicate of the hormone made in the human body.

    The following preliminary, non-clinical evidence supports the idea that activated vitamin D may be of help to some breast cancer patients:

    • In combination with tamoxifen, a synthetic, activated-vitamin D-like molecule has inhibited the growth of breast cancer cells in test tube research.95
    • Synthetic vitamin D-like molecules induce tumor cell death in breast cancer cells.96
    • Activated vitamin D suppresses the growth of human cancer cells transplanted into animals.97
    • In test tube research, activated vitamin D has increased the anticancer action of chemotherapy.98

    In a preliminary trial, activated vitamin D was applied topically to the breast, once per day for six weeks, in 19 patients with breast cancer.99 Of the 14 patients who completed the trial, three showed a large reduction in tumor size, and one showed a minor improvement. Those who responded had tumors that contained receptors for activated vitamin D. However, other preliminary reports have not found that high levels of these receptors consistently correlate with a better outcome.100,101,102

    With a doctor’s prescription, compounding pharmacists can put activated vitamin D, a hormone, into a topical ointment. Due to potential toxicity, use of this hormone, even topically, requires careful monitoring by a physician. Standard vitamin D supplements are unlikely to duplicate the effects of activated vitamin D in women with breast cancer. The patients in the breast cancer trial all had locally advanced disease.

    Amenorrhea and Osteoporosis

    Despite the lack of evidence that calcium and vitamin D supplements alone are helpful to amenorrheic women, they are still generally recommended to prevent the added burden of calcium and vitamin D deficiency from further contributing to bone loss.
    Amenorrhea and Osteoporosis
    ×
     

    A preliminary trial showed that bone loss occurred over a one-year period in amenorrheic exercising women despite daily supplementation with 1,200 mg of calcium and 400 IU of vitamin D.103 In a controlled study of amenorrheic nursing women, who ordinarily experience brief bone loss that reverses when menstruation returns, bone loss was not prevented by a multivitamin supplement providing 400 IU of vitamin D along with 500 mg twice daily of calcium or placebo.104 Despite the lack of evidence that calcium and vitamin D supplements alone are helpful to amenorrheic women, they are still generally recommended to prevent the added burden of calcium and vitamin D deficiency from further contributing to bone loss.105 Amounts typically recommended are 1,200 to 1,500 mg calcium and 400 to 800 IU vitamin D daily.

  • Joint Health

    Low Back Pain

    In people with muscle pain associated with vitamin D deficiency, supplementing with the vitamin may improve pain.
    Low Back Pain
    ×
    Some studies have found that vitamin D levels are lower in people with back pain than in healthy people.106,107 In patients with muscle pain associated with vitamin D deficiency, vitamin D supplementation has resulted in improvement in the pain.108
  • Digestive Support

    Crohn’s Disease

    Vitamin D malabsorption is common in Crohn’s and can lead to a deficiency of the vitamin. Supplementation can help prevent bone loss in cases of deficiency.
    Crohn’s Disease
    ×

    Vitamin D malabsorption is common in Crohn’s109 and can lead to a deficiency of the vitamin.110 Successful treatment with vitamin D for osteomalacia (bone brittleness caused by vitamin D deficiency) triggered by Crohn’s disease has been reported.111 Another study found 1,000 IU per day of vitamin D prevented bone loss in people with Crohn’s, while an unsupplemented group experienced significant bone loss.112 In addition, in a double-blind trial, vitamin D supplementation (1,200 IU per day for 12 months) prevented relapses in patients with Crohn's disease in remission. The patients in that study had normal vitamin D status prior to receiving vitamin D supplementation.113 In a preliminary study of patients with mild-to-moderate Crohn's disease, vitamin D supplementation for 24 weeks was associated with an improvement in disease activity. The amount used in that study was 1,000 to 5,000 IU per day, based on blood levels of the vitamin.114 A doctor should be consulted to determine the right level of vitamin D for supplementation.

    Celiac Disease

    Malabsorption-induced vitamin D deficiency can lead to bone weakening in people with celiac disease. Supplementing with vitamin D may help increase bone density.
    Celiac Disease
    ×
     

    The malabsorption that occurs in celiac disease can lead to multiple nutritional deficiencies. The most common nutritional problems in people with celiac disease include deficiencies of essential fatty acids, iron, vitamin D, vitamin K, calcium, magnesium, and folic acid.115Zinc malabsorption also occurs frequently in celiac disease116 and may result in zinc deficiency, even in people who are otherwise in remission.117 People with newly diagnosed celiac disease should be assessed for nutritional deficiencies by a doctor. Celiac patients who have not yet completely recovered should supplement with a high-potency multivitamin-mineral. Some patients may require even higher amounts of some of these vitamins and minerals—an issue that should be discussed with their healthcare practitioner. Evidence of a nutrient deficiency in a celiac patient is a clear indication for supplementation with that nutrient.

    After commencement of a gluten-free diet, overall nutritional status gradually improves. However, deficiencies of some nutrients may persist, even in people who are strictly avoiding gluten. For example, magnesium deficiency was found in 8 of 23 adults with celiac disease who had been following a gluten-free diet and were symptom-free. When these adults were supplemented with magnesium for two years, their bone mineral density increased significantly.118

    Malabsorption-induced depletion of vitamin D can lead to osteomalacia (defective bone mineralization) in people with celiac disease.119 Although supplementation with vitamin D appears to increase bone density, the excess risk of bone fracture may not be entirely eliminated.

  • Allergy and Lung Support

    Asthma

    One study found that daily supplementation with vitamin D during the winter months significantly reduced the amount of times the children experienced asthma attacks.
    Asthma
    ×
    In a double-blind study of Japanese children (average age, ten years), supplementation with 1,200 IU per day of vitamin D for 15 to 17 weeks during the winter significantly reduced the incidence of asthma attacks compared with a placebo.120 In another double-blind study, however, vitamin D (2,000 IU per day for 15 weeks) did not provide any clear benefit in children with asthma.121 Vitamin D has not been found to be beneficial for adults with asthma.122
  • Menstrual and PMS Support

    Dysmenorrhea

    In a double-blind trial, women with dysmenorrhea received a placebo or a single administration of a large amount of vitamin D, which appeared to significantly diminish menstrual pain. This should only be done under doctor supervision.
    Dysmenorrhea
    ×
    In a double-blind trial, women with dysmenorrhea received a placebo or a single administration of a large amount of vitamin D (300,000), five days before the expected onset of the next menstrual period. During the next two menstrual periods, menstrual pain was significantly lower in the vitamin D group than in the placebo group.123 Such a large amount of vitamin D should be given only under the supervision of a doctor. Further research is needed to determine whether daily supplementation of a smaller amount (such as 800 to 2,000 IU per day) would have a similar beneficial effect.

    Amenorrhea and Osteoporosis

    Despite the lack of evidence that calcium and vitamin D supplements alone are helpful to amenorrheic women, they are still generally recommended to prevent the added burden of calcium and vitamin D deficiency from further contributing to bone loss.
    Amenorrhea and Osteoporosis
    ×
     

    A preliminary trial showed that bone loss occurred over a one-year period in amenorrheic exercising women despite daily supplementation with 1,200 mg of calcium and 400 IU of vitamin D.124 In a controlled study of amenorrheic nursing women, who ordinarily experience brief bone loss that reverses when menstruation returns, bone loss was not prevented by a multivitamin supplement providing 400 IU of vitamin D along with 500 mg twice daily of calcium or placebo.125 Despite the lack of evidence that calcium and vitamin D supplements alone are helpful to amenorrheic women, they are still generally recommended to prevent the added burden of calcium and vitamin D deficiency from further contributing to bone loss.126 Amounts typically recommended are 1,200 to 1,500 mg calcium and 400 to 800 IU vitamin D daily.

  • Kidney and Urinary Tract Health

    Urinary Incontinence

    Higher blood levels of vitamin D are associated with lower risk of urinary incontinence in women.
    Urinary Incontinence
    ×
    Vitamin D may be important for normal muscle function, including muscles that help control urinary continence.127,128 Higher blood levels of vitamin D are associated with lower risk of urinary incontinence in women, according to one preliminary study.129 Controlled trials are needed to determine whether vitamin D supplements can help prevent or treat urinary incontinence.
  • Prostate Support

    Prostate Cancer

    Where sun exposure is low, the rate of prostate cancer has been reported to be high.
    Prostate Cancer
    ×
    Where sun exposure is low, the rate of prostate cancer has been reported to be high.130,131 In the body, vitamin D is changed into a hormone with great activity. This activated vitamin D causes “cellular differentiation”—essentially the opposite of cancer.
  • Sleep Support

    Restless Legs Syndrome

    In one small study, in people with a vitamin D blood level below 20 ng/ml, vitamin D supplementation decreased the severity of restless legs syndrome.
    Restless Legs Syndrome
    ×
    In a study of 12 Saudi Arabian adults, the average blood level of vitamin D (measured as 25-hydroxyvitamin D) was very low (8.7 ng/ml). In people with a level below 20 ng/ml, vitamin D supplementation decreased the severity of restless legs syndrome by 62%.132 Double-blind trials are needed to confirm this study
  • Children's Health

    Autism

    In a preliminary study and a follow-up double-blind study of autistic children, daily supplementation with vitamin D was associated with improvements in various symptoms of autism.
    Autism
    ×
    In a preliminary study and a follow-up double-blind study of Egyptian autistic children, daily supplementation with vitamin D for 3 to 4 months was associated with improvements in various symptoms of autism, including irritability, hyperactivity, social withdrawal, inappropriate speech, stereotypical behavior, and communication.. The amount of vitamin D given was 136 IU per pound of body weight, with a maximum of 5,000 IU per day.133 Since the amount of vitamin D used in the study was relatively large and could potentially cause adverse effects, this treatment should be monitored by a doctor.
What Are Star Ratings?
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.

For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.

×

References

1. Al Faraj S, Al Mutairi K. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine 2003;28:177-9.

2. Lotfi A, Abdel-Nasser AM, Hamdy A, et al. Hypovitaminosis D in female patients with chronic low back pain. Clin Rheumatol 2007;26:1895-901.

3. De Torrente de la Jara G, Pecoud A, Favrat B. Musculoskeletal pain in female asylum seekers and hypovitaminosis D3. BMJ 2004;329:156-7.

4. Prakash S, Shah ND. Chronic tension-type headache with vitamin D deficiency: casual or causal association? Headache 2009;49:1214-22.

5. Wepner F, Scheuer R, Schuetz-Wieser B, et al. Effects of vitamin D on patients with fibromyalgia syndrome: A randomized placebo-controlled trial. Pain 2014;155:261–8.

6. Klein GL, Chen TC, Holick MF, et al. Synthesis of vitamin D in skin after burns. Lancet 2004;363:291-2.

7. Garrel D. Burn scars: a new cause of vitamin D deficiency? Lancet 2004;363:259-60.

8. Thys-Jacobs S. Vitamin D and calcium in menstrual migraine. Headache 1994;34:544-6.

9. Thys-Jacobs S. Alleviation of migraines with therapeutic vitamin D and calcium. Headache 1994;34:590-2.

10. Brot C, Jorgensen N, Madsen OR, et al. Relationships between bone mineral density, serum vitamin D metabolites and calcium: phosphorus intake in healthy perimenopausal women. J Intern Med 1999;245:509-16.

11. Sahota O. Osteoporosis and the role of vitamin D and calcium-vitamin D deficiency, vitamin D insufficiency and vitamin D sufficiency. Age Ageing 2000;29:301-4.

12. Dawson-Hughes B, Dallal GE, Krall EA, et al. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505-12.

13. Adams JS, Kantorovich V, Wu C, et al. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab 1999;84:2729-30.

14. Macdonald HM, Wood AD, Aucott LS, et al. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: a 1-year double-blind RCT in postmenopausal women. J Bone Miner Res 2013;28:2202–13.

15. Nordin BE, Baker MR, Horsman A, Peacock M. A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 1985;42(3):470-4.

16. Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly persons. Ann Intern Med 1996;124:400-6.

17. Komulainen M, Tuppurainen MT, Kroger H, et al. Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study. Osteoporosis Int 1997;7:126-32.

18. Droisy R, Collette J, Chevallier T, et al. Effects of two 1-year calcium and vitamin D3 treatments on bone remodeling markers and femoral bone density in elderly women. Curr Ther Res 1998;59:850-62.

19. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42.

20. Maki BE, Holliday PJ, Topper AK. A prospective study of postural balance and risk of falling in an ambulatory and independent elderly population. J Gerontol 1994;49:M72-84.

21. Leboff MS, Hawkes WG, Glowacki J, et al. Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 2008;19:1283-90.

22. Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000;15:1113-8.

23. Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007;55:234-9.

24. Abraham GE, Grewal H. A total dietary program emphasizing magnesium instead of calcium. J Reprod Med 1990;35:503-7.

25. Hyppönen E, Boucher BJ. Adiposity, vitamin D requirements, and clinical implications for obesity-related metabolic abnormalities. Nutr Rev 2018 09;76(9):678–692.

26. Slusher AL, McAllister MJ, Huang CJ. A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention. Inflamm Res 2015 Aug;64(8):565–75.

27. Lotfi-Dizaji L, Mahboob S, Aliashrafi S, et al. Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: A double-blind placebo-controlled randomized clinical trial. Clin Endocrinol (Oxf) 2019 01;90(1):94–101.

28. Abboud M, Liu X, Fayet-Moore F, et al. Effects of Vitamin D Status and Supplements on Anthropometric and Biochemical Indices in a Clinical Setting: A Retrospective Study. Nutrients 2019 Dec;11(12):3032.

29. Mason C, Xiao L, Imayama I, et al. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 2014 May;99(5):1015–25.

30. Rak K, Bronkowska M. Immunomodulatory Effect of Vitamin D and Its Potential Role in the Prevention and Treatment of Type 1 Diabetes Mellitus-A Narrative Review. Molecules 2018;24.

31. Maddaloni E, Cavallari I, Napoli N, Conte C. Vitamin D and Diabetes Mellitus. Front Horm Res 2018;50:161–76.

32. Grammatiki M, Karras S, Kotsa K. The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative review. Hormones (Athens) 2019;18:37–48.

33. Cadario F, Savastio S, Ricotti R, et al. Administration of vitamin D and high dose of omega 3 to sustain remission of type 1 diabetes. Eur Rev Med Pharmacol Sci 2018;22:512–5.

34. Cadario F, Savastio S, Rizzo A, et al. Can Type 1 diabetes progression be halted? Possible role of high dose vitamin D and omega 3 fatty acids. Eur Rev Med Pharmacol Sci 2017;21:1604–9.

35. Gregoriou E, Mamais I, Tzanetakou I, et al. The Effects of Vitamin D Supplementation in Newly Diagnosed Type 1 Diabetes Patients: Systematic Review of Randomized Controlled Trials. Rev Diabet Stud 2017;14:260–8.

36. Felicio K, de Souza A, Neto J, et al. Glycemic Variability and Insulin Needs in Patients with Type 1 Diabetes Mellitus Supplemented with Vitamin D: A Pilot Study Using Continuous Glucose Monitoring System. Curr Diabetes Rev 2018;14:395–403.

37. Bogdanou D, Penna-Martinez M, Filmann N, et al. T-lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: A randomized controlled trial with sequential crossover. Diabetes Metab Res Rev 2017;33.

38. Wierzbicka E, Szalecki M, Pludowski P, et al. Vitamin D status, body composition and glycemic control in Polish adolescents with type 1 diabetes. Minerva Endocrinol 2016;41:445–55.

39. Savastio S, Cadario F, Genoni G, et al. Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus. PLoS One 2016;11:e0162554.

40. Hafez M, Hassan M, Musa N, et al. Vitamin D status in Egyptian children with type 1 diabetes and the role of vitamin D replacement in glycemic control. J Pediatr Endocrinol Metab 2017;30:389–94.

41. Aljabri K, Bokhari S, Khan M. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med 2010;30:454–8.

42. Grammatiki M, Karras S, Kotsa K. The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative review. Hormones (Athens) 2019;18:37–48.

43. Leung P. The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. Nutrients 2016;8:147.

44. Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D. Curr Diab Rep 2019;19:101.

45. Rafiq S, Jeppesen P. Is Hypovitaminosis D Related to Incidence of Type 2 Diabetes and High Fasting Glucose Level in Healthy Subjects: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients 2018;10.

46. Li X, Liu Y, Zheng Y, et al. The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis. Nutrients 2018;10.

47. Wu C, Qiu S, Zhu X, Li L. Vitamin D supplementation and glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Metabolism 2017;73:67–76.

48. Lee C, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies. J Diabetes Complications 2017;31:1115–26.

49. Mirhosseini N, Vatanparast H, Mazidi M, Kimball S. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab 2017;102:3097–110.

50. Alam U, Arul-Devah V, Javed S, Malik R. Vitamin D and Diabetic Complications: True or False Prophet? Diabetes Ther 2016;7:11–26.

51. Moukayed M, Grant W. Linking the metabolic syndrome and obesity with vitamin D status: risks and opportunities for improving cardiometabolic health and well-being. Diabetes Metab Syndr Obes 2019;12:1437–47.

52. Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D. Curr Diab Rep 2019;19:101.

53. Wimalawansa S. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J Steroid Biochem Mol Biol 2018;175:177–89.

54. Grober U, Holick M. Diabetes Prevention: Vitamin D Supplementation May Not Provide Any Protection If There Is No Evidence of Deficiency! Nutrients 2019;11.

55. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 2008;168:771-2.

56. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007;135:1095-6.

57. Camargo CA Jr, Ganmaa D, Frazier AL, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012;130:e561-e567.

58. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol Infect 2007;135:1095-6.

59. Laaksi I, Ruohola JP, Mattila V, et al. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 2010;202:809–14.

60. Grant CC, Kaur S, Waymouth E, et al. Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial. Acta Paediatr 2015;104:396–404.

61. Rees JR, Hendricks K, Barry EL, et al. Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis 2013;57:1384–92.

62. Denlinger LC, King TS, Cardet JC, et al. Vitamin D supplementation and the risk of colds in patients with asthma. Am J Respir Crit Care Med 2016;193:634–41.

63. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 2013;40:265–72.

64. Lima GL, Paupitz J, Aikawa NE, et al. A randomized double-blind placebo-controlled trial of vitamin D supplementation in adolescents and young adults with juvenile-onset SLE: improvement in disease activity and fatigue scores. Arthritis Care Res 2015 May 18 [Epub ahead of print].

65. Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91:1255-60.

66. de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, et al. Vitamin D and cardiovascular health. Clin Nutr 2021;40:2946–57.

67. Lin L, Zhang L, Li C, et al. Vitamin D and Vitamin D Receptor: New Insights in the Treatment of Hypertension. Curr Protein Pept 2019;20:984–95.

68. Zhang D, Cheng C, Wang Y, et al. Effect of Vitamin D on Blood Pressure and Hypertension in the General Population: An Update Meta-Analysis of Cohort Studies and Randomized Controlled Trials. Prev Chronic Dis 2020;17:E03.

69. Legarth C, Grimm D, Wehland M, et al. The Impact of Vitamin D in the Treatment of Essential Hypertension. Int J Mol Sci 2018;19:455.

70. He S, Hao X. The effect of vitamin D3 on blood pressure in people with vitamin D deficiency: A system review and meta-analysis. Medicine (Baltimore) 2019;98:e15284.

71. Zhu YB, Li ZQ, Ding N, et al. The association between vitamin D receptor gene polymorphism and susceptibility to hypertension: a meta-analysis. Eur Rev Med Pharmacol Sci 2019;23:9066–74.

72. Gotsman I, Shauer A, Zwas DR, et al. Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome. Eur J Heart Fail 2012;14:357-66.

73. Ford JA, MacLennan GS, Avenell A, et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am J Clin Nutr 2014;100:746–755.

74. Kessel L. Sick sinus syndrome cured by...vitamin D? Geriatrics 1990;45(8):83-5.

75. Hoogendijk WJ, Lips P, Dik MG, et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008;65:508-12.

76. Lansdowne ATG, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 1998;135:319-23.

77. Arasteh K. A beneficial effect of calcium intake on mood. J Orthomolec Med 1994;9:199-204.

78. Khoraminya N, Tehrani-Doost M, Jazayeri S, et al. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder. Aust N Z J Psychiatry 2012;Oct 23:[Epub ahead of print].

79. Stumpf WE, Privette TH. Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology (Berl) 1989;97:285-94 [review].

80. Gloth FM III, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999;3:5-7.

81. Frandsen TB, Pareek M, Hansen JP, Nielsen CT. Vitamin D supplementation for treatment of seasonal affective symptoms in healthcare professionals: a double-blind randomised placebo-controlled trial. BMC Res Notes 2014;7:528.

82. Samochocki Z, Bogaczewicz J,Jeziorkowska R, et al. Vitamin D effects in atopic dermatitis. J Am Acad Dermatol 2013 May 2 [Epub ahead of print].

83. Camargo CA Jr, Ganmaa D, Sidbury R, et al. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 2014;134:831-835.e1.

84. Hata TR, Audish D, Kotol P, et al. A randomized controlled double-blind investigation of the effects of vitamin D dietary supplementation in subjects with atopic dermatitis. J Eur Acad Dermatol Venereol 2013;May 3:[Epub ahead of print].

85. Klein GL, Chen TC, Holick MF, et al. Synthesis of vitamin D in skin after burns. Lancet 2004;363:291-2.

86. Garrel D. Burn scars: a new cause of vitamin D deficiency? Lancet 2004;363:259-60.

87. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: A preliminary study. Pediatr Dermatol 1999;16:317-20.

88. Taheri M, Baheiraei A, Foroushani AR, et al. Treatment of vitamin D deficiency is an effective method in the elimination of asymptomatic bacterial vaginosis: A placebo-controlled randomized clinical trial. Indian J Med Res 2015;141:799–806.

89. Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Arch Intern Med 2012;172:366-7.

90. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990;19:820-4.

91. Anzano MA, Smith JM, Uskokovic, et al. 1a,25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res 1994;54:1653-6.

92. Demdirpence E, Balaguer P, Trousse F, et al. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 1994;54:1458-64.

93. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. Cancer Epidemiol Biomarkers Prev 1999;8:399-406.

94. Robien K, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control 2007;18:775-82.

95. Vink-van Wijngaarden T, Pols HA, Buurman CJ, et al. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen. Cancer Res 1994;54:5711-7.

96. James SY, Merceer E, Brady M, et al. ERB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol 1998;125:953-62.

97. Eisman JA, Barkla DH, Tutton PJM. Suppression of in vitro growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res 1987;47:21-5.

98. Ravid A, Rocker D, Machlenkin A, et al. 1,25-dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage. Cancer Res 1999;59:862-7.

99. Bower M, Colston KW, Stein RC, et al. Topical calcipotriol treatment in advanced breast cancer. Lancet 1991;337:701-2.

100. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1989;I:188-91.

101. Eisman JA, Suva LJ, Martin TJ. Significance of 1,25-dihydroxyvitamin D3 receptor in primary breast cancer. Cancer Res 1986;46:5406-8.

102. Freake HC, Abeyasekera G, Iwasaki J, et al. Measurement of 1,25-dihydroxyvitamin D3 receptors in breast cancer and their relationship to biochemical and clinical indices. Cancer Res 1984;44:1677-81.

103. Baer JT, Taper LJ, Gwazdauskas FG, et al. Diet, hormonal, and metabolic factors affecting bone mineral density in adolescent amenorrheic and eumenorrheic female runners. J Sports Med Phys Fitness 1992;32:51-8.

104. Kalkwarf HJ, Specker BL, Ho M. Effects of calcium supplementation on calcium homeostasis and bone turnover in lactating women. J Clin Endocrinol Metab 1999;84:464-70.

105. Fagan KM. Pharmacologic management of athletic amenorrhea. Clin Sports Med 1998;17:327-41 [review].

106. Al Faraj S, Al Mutairi K. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine 2003;28:177-9.

107. Lotfi A, Abdel-Nasser AM, Hamdy A, et al. Hypovitaminosis D in female patients with chronic low back pain. Clin Rheumatol 2007;26:1895-901.

108. De Torrente de la Jara G, Pecoud A, Favrat B. Musculoskeletal pain in female asylum seekers and hypovitaminosis D3. BMJ 2004;329:156-7.

109. Leichtmann GA, Bengoa JM, Bolt MJG, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydrocycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr 1991;54:548-52.

110. Harris AD, Brown R, Heatley RV, et al. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985;26:1197-203.

111. Driscoll RH Jr, Meredith SC, Sitrin M, et al. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982;83:1252-8.

112. Vogelsang H, Ferenci P, Resch H, et al. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609-14.

113. Jorgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010;32:377-83.

114. Yang L, Weaver V, Smith JP, et al. Therapeutic effect of vitamin D supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol 2013;4:e33.

115. Connon JJ. Celiac disease. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease, 8th ed. Philadelphia: Lea & Febiger, 1994, 1062.

116. Crofton RW, Glover SC, Ewen SWB, et al. Zinc absorption in celiac disease and dermatitis herpetiformis: a test of small intestinal function. Am J Clin Nutr 1983;38:706-12.

117. Solomons NW, Rosenberg IH, Sandstead HH. Zinc nutrition in celiac sprue. Am J Clin Nutr 1976;29:371-5.

118. Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 1996;6:453-61.

119. Basha B, Rao S, Han ZH, Parfitt, AM. Osteomalacia due to vitamin D depletion: neglected consequence of intestinal malabsorption. Am J Med 2000;108(4):296-300.

120. Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91:1255-60.

121. Kerley CP, Hutchinson K, Cormican L, et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Pediatr Allergy Immunol 2016;27:404–12.

122. Castro M, King TS, Kunselman SJ, et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA 2014;311:2083–91.

123. Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Arch Intern Med 2012;172:366-7.

124. Baer JT, Taper LJ, Gwazdauskas FG, et al. Diet, hormonal, and metabolic factors affecting bone mineral density in adolescent amenorrheic and eumenorrheic female runners. J Sports Med Phys Fitness 1992;32:51-8.

125. Kalkwarf HJ, Specker BL, Ho M. Effects of calcium supplementation on calcium homeostasis and bone turnover in lactating women. J Clin Endocrinol Metab 1999;84:464-70.

126. Fagan KM. Pharmacologic management of athletic amenorrhea. Clin Sports Med 1998;17:327-41 [review].

127. Crescioli C, Morelli A, Adorini L, et al. Human bladder as a novel target for vitamin D receptor ligands. J Clin Endocrinol Metab 2005;90:962-72.

128. Schröder A, Colli E, Maggi M, Andersson KE. Effects of vitamin D(3) analogue in a rat model of bladder outlet obstruction. BJU Int 2006;98:637-42.

129. 3] Badalian SS, Rosenbaum PF. Vitamin D and pelvic floor disorders in women: results from the National Health and Nutrition Examination Survey. Obstet Gynecol 2010;115:795-803.

130. Studzinski GP, Moore DC. Sunlight--can it prevent as well as cause cancer? Cancer Res 1995;55:4014-22 [review].

131. John EM, Koo J, Schwartz GG. Sun exposure and prostate cancer risk: evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev 2007;16:1283-6.

132. Wali S, Shukr A, Boudal A, et al. The effect of vitamin D supplements on the severity of restless legs syndrome. Sleep Breath 2015;19:579–83.

133. Saad K, Abdel-Rahman AA, Elserogy YM, et al. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry 2016 Nov 21 [Epub ahead of print].

134. Gaby, AR. Nutritional Medicine. Concord, NH: Fritz Perlberg Publishing, 2011.

135. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.

136. Dawson-Hughes B. Calcium and vitamin D nutritional needs of elderly women. J Nutr 1996;126(4 Suppl):1165-7S.

137. Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42.

138. Dawson-Hughes B, Harris SS, Krall EA, et al. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995;61:1140-5.

139. Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000;247:260-8.

140. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.

141. Moreira-Pfrimer LDF, Pedrosa MAC, Teixeira L, Lazaretti-Castro M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab 2009;54:291-300.

142. Agarwal KS, Mughal MZ, Upadhyay P, et al. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi, India. Arch Dis Child 2002;87:111-3.

143. Manicourt DH, Devogelaer JP. Urban tropospheric ozone increases the prevalence of vitamin D deficiency among Belgian postmenopausal women with outdoor activities during summer. J Clin Endocrinol Metab 2008;93:3893-9.

144. Kyriakidou-Himonas M, Aloia JF, Yeh JK. Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab 1999;84:3988-90.

145. Basha B, Rao S, Han ZH, Parfitt, AM. Osteomalacia due to vitamin D depletion: neglected consequence of intestinal malabsorption. Am J Med 2000;108(4):296-300.

146. Yamashita H, Noguchi S, Takatsu K, et al. High prevalence of vitamin D deficiency in Japanese female patients with Graves' disease. Endocr J 2001;48(6):63-9.

147. Silverberg SL, Shane E, Dempster DW, Bilezikian JP. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 1999; 107:561-7.

148. Van Veldhuizen PJ, Taylor SA, Williamson S, Drees BM. Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. J Urol 2000;163:187-90.

149. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439-43.

150. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777-83.

151. Harris SS, Dawson-Hughes B, Perrone GA. Plasma 25-hydroxyvitamin D responses of younger and older men to three weeks of supplementation with 1800 IU/day of vitamin D. J Am Coll Nutr 1999;18:470-4.

152. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56.

153. Heikkinen AM, Tuppurainen MT, Komulainen M, et al. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 1997;137:495-502.

154. Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 1995;49:640-6.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;